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ABSTRACT
This study examined the relationships among sociodemographic factors, social support, cop-
ing, and adherence to antiretroviral therapy (ART) among HIV-positive women with depres-
sion. The analyses reported here were limited to the 224 women receiving ART of 280 women
recruited from community-based HIV/AIDS organizations serving rural areas of three states
in the southeastern United States. Two indicators of medication adherence were measured;
self-report of missed medications and reasons for missed medications in the past month. De-
scriptive statistics, correlation, and regression analyses were performed to systematically iden-
tify sociodemographic, coping, and social support variables that predicted medication ad-
herence. In regression analysis, three variables were determined to be significant predictors
accounting for approximately 30% of the variability in the self-report of reasons for missed
medications. Coping focused on managing HIV disease was negatively associated, while cop-
ing focused on avoidance/denial and number of children were positively associated with rea-
sons for missed medications. Coping by spiritual activities and focusing on the present me-
diated the effect of social support on self-reported missed medications. The relationship of
predictor variables to self-report of missed medications was assessed using t test statistics
and logistic regression analysis to determine the odds of self-reported medication adherence.
Satisfaction with social support (p  0.04), and coping focused on managing HIV disease (p 
0.002) were the best positive predictors, whereas number of children (p  0.02) was the lone
significant negative predictor of medication adherence. The study findings have implications
for designing, implementing, and testing interventions based on social support and coping
theories for achieving better adherence to HIV medications.
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INTRODUCTION
WITH THE ADVENT of antiretroviral medica-tions, improvements in treatment op-
tions, and introduction of highly active anti-
retroviral therapy (HAART), HIV disease has
undergone a transition from an acute terminal
illness to a chronic illness. Treatment with
1Arnold School of Public Health, 2College of Nursing, 3Rural Women’s Health Project, University of South Car-
olina, Columbia, South Carolina.
4School of Nursing, the University of Arizona, Tucson, Arizona.
HAART has been shown to suppress viral
loads to undetectable levels in many patients.1
Continuous viral suppression, which is a pri-
mary goal of medical management of HIV in-
fection, results in longer and healthier lives for
HIV-positive individuals.2 Viral replication
dramatically increases within days after with-
drawing or missing antiretroviral doses.3 Fail-
ure to adhere to HAART not only results in
treatment failure but also in the development
of drug-resistant strains of HIV.4 It is esti-
mated that in the United States, as many as
50% of persons with HIV disease who have
been treated with HAART now have strains
of HIV that are resistant to at least one of the
available antiretroviral drugs.5 Persons who
do not maintain a 95% adherence rate to
HAART are at risk for treatment failure and
adverse clinical outcomes.4 Once established,
resistance may become irreversible through 
a process of evolution and diversification.5
Therefore, strict adherence to the prescribed
drug regimen is a critical factor in controlling
progression of the disease, thereby reducing
morbidity and mortality in individuals with
HIV disease.
Achieving a nearly perfect adherence to a
complex regimen of medications is a remark-
ably difficult and challenging task.2,6,7 Despite
the efforts of health care professionals to en-
courage adherence, many individuals with
HIV disease continue to miss doses, take lower
doses than prescribed or fail to take their med-
ications as directed.8
Numerous studies have focused on identify-
ing factors influencing medication adherence.
Many of these studies have focused on barri-
ers to adherence such as depression and sub-
stance abuse. Both social support and coping
are known factors influencing the outcomes of
chronic illness, and many studies have focused
on the roles social support and coping may
play in medication adherence within the con-
text of HIV disease.9 However, very little is
known about the population of rural women
living with HIV disease, including factors that
may influence their adherence to ART medica-
tion regimens. Given the geographical and so-
cial barriers to needed support and services
faced by individuals with HIV disease living in
rural areas, an examination of factors influenc-
ing the medication adherence of rural women
is warranted.
This study examined the relationships
among perceived social support, coping strate-
gies and antiretroviral medication adherence in
a sample of 224 rural women with HIV disease,
a subset of participants enrolled in a longitu-
dinal clinical trial designed to test the efficacy
of a peer-based social support intervention. The
cross-sectional data used in the analyses were
obtained during baseline interviews with study
participants. Based on theory of psychological
stress, coping, and adaptation, analyses were
conducted to examine the predictive value of
both social support and coping for adherence,
and also to examine the role of coping as a me-
diator of the relationship between social sup-
port and medication adherence.
BACKGROUND
The theoretical perspective guiding this anal-
ysis is Lazarus and colleagues’ cognitive–phe-
nomenological model of psychological stress and
coping, which identifies the antecedents and pro-
cesses that account for individual differences in
adaptational outcomes of stressful life situations
such as chronic illness.10–12 Important to the pres-
ent study are the roles of social support and cop-
ing in accounting for individual differences in
medication adherence within the context of HIV
disease among rural women.
Social support is conceptualized as one of a
number of antecedent stress resistance re-
sources that contribute to positive adaptational
outcomes.10–12 Having people in one’s life dur-
ing a stressful episode from whom one receives
emotional, informational, and/or tangible sup-
port is a major factor mediating such outcomes.
It is postulated that individuals who have ac-
cess to resources such as social support are
more likely to be effective in managing stress-
ful situations and less likely to experience poor
outcomes. Conversely, those who are deficient
in resources such as social support are less able
to manage the situation effectively, and thus
are more likely to experience negative out-
comes.12 Extensive evidence suggests that so-
cial support contributes to positive adapta-
tional outcomes, even in the most difficult of
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situations, and its absence contributes to poor
outcomes. For example, social support has been
found to mitigate depressive symptoms of
HIV-positive individuals.13
Social support is a complex construct that is
difficult to define and measure. The general
consensus is that social support is a multidi-
mensional construct that includes the sources
of support, i.e., who in the social network pro-
vides support, the types of support (e.g., emo-
tional, informational, or tangible), and one’s
satisfaction with the support received.14 There
is less agreement concerning what constitutes
social support, how it works, and what types
of support are most effective in a particular
context. Although the emphasis of research has
been on the positive dimensions of social sup-
port, it is acknowledged that some attempts at
support are actually perceived by the recipient
to be unhelpful or negative and undesirable.15
The desirability and potential effectiveness of
different types of support depend to a great ex-
tent on the context of the situation and the type
of support needed, and support may be per-
ceived negatively when the support provided
does not match the needs of the situation.12
In stress theory, coping is conceptualized as
a process that mediates the relationship be-
tween the antecedents and outcomes of psy-
chological stress. Coping responses include all
cognitive and behavioral strategies used by in-
dividuals to manage a stressful situation. There
are two major functions of coping: (1) man-
agement of emotional distress and (2) man-
agement of those problems causing psycholog-
ical stress.12 A number of coping strategies,
primarily cognitive in nature, focus on manag-
ing one’s emotional distress; such strategies are
called emotion-focused coping strategies. In
contrast, coping strategies that focus on man-
aging the situation causing distress are called
problem-focused coping strategies. It is postu-
lated that the effectiveness of any one coping
strategy is dependent upon the match between
the strategy and what is needed in the situa-
tion.12 In situations of chronic illness, there is
extensive evidence that problem-focused cop-
ing strategies are more effective in producing
positive adaptational outcomes over the long-
term than emotion-focused strategies.13,16,17
Similar findings have been reported in studies
of coping with HIV disease.18 Similar to social
support, coping strategies must match the de-
mands of the situation to be effective.12
Medication adherence is an important adap-
tational outcome for HIV disease. As noted pre-
viously, HIV patients must show a high level of
adherence to HAART to suppress viral loads
and avoid development of resistant strains of the
virus. It is estimated that adherence rates greater
than 95% are necessary to achieve maximum
HIV suppression.19 Failure to adhere to a med-
ication regimen results in virologic failure,
which is defined as an increase in the rates of
viral replication and mutation following initia-
tion of the regimen.20 It is estimated that aver-
age rates of nonadherence to antiretroviral ther-
apy range from 50% to 70%.21 Understanding of
those factors contributing to adherence as well
as nonadherence is essential to the development
of interventions that are predictably effective in
promoting adherence. Recent efforts to test
interventions tailored to address such factors
have demonstrated effectiveness in increasing
adherence. Deschamps and colleagues22 re-
ported nonadherence rate of 40% in a popula-
tion of HIV patients using medication event
monitoring system. Findings from another
study suggested that appropriately trained
HIV/AIDS case managers can play a pivotal
role in improving HAART adherence among
their clients.23 Recent multidisciplinary pro-
grams have successfully increased HAART ad-
herence among intervention participants as
compared to those in the control group.24
Many studies in the past have examined the
association between availability of social sup-
port and HIV medication adherence. Cox9 found
emotional support to be a significant predictor
of medication drug adherence among persons
with HIV disease. Other studies found per-
ceived social support to be a significant predic-
tor of compliance.25,26 Some studies have exam-
ined how coping strategies influence medication
adherence in individuals with HIV disease. In
one such study, Heckman and colleagues27
found active coping strategies to be positively
associated with medication adherence.
A model of medication adherence within the
context of HIV disease is shown in Figure 1.
The model demonstrates the link between an-
tecedent factors, including sociodemographic
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variables and social support variables, and the
outcome of HIV medication adherence. Addi-
tionally, coping strategies are included as pro-
cess variables that mediate the relationship 
between social support and medication adher-
ence and account for individual differences.
The analysis reported here was an attempt to
increase understanding of the relationships
among social support, coping, and medication
adherence among individuals with HIV dis-
ease as a means of identifying potential points
of intervention that will support HIV medica-
tion adherence.
METHODS
The cross-sectional data reported here were
collected in the first of three interviews of a
longitudinal study designed to test the efficacy
of a peer-based social support intervention de-
signed for rural women with HIV disease and
depression.
Sample
The original sample included 280 HIV-in-
fected women recruited from 10 community-
based HIV/AIDS service organizations serving
rural areas of 3 states in the southeastern
United States. The analysis was limited to the
subset of 224 participants who were currently
receiving antiretroviral therapy. Each recruit-
ment site provided a range of standard
HIV/AIDS specific services, including HIV
testing and counseling, early intervention, case
management, and treatment. Criteria for inclu-
sion in the study were: (1) residence in a rural
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FIG. 1. Model of social support, coping and HIV medication adherence.
area or town with a population less than 50,000;
(2) age 18 or older; (3) verified HIV-positive sta-
tus; (4) English-speaking; (5) no evidence of de-
mentia verified by medical records; (6) no prior
peer counseling experience; and (7) a score of
16 or higher on the Center for Epidemiological
Studies-Depression (CES-D) scale. The cutoff
point of 16 was selected, as scores at this level
or higher are significantly correlated with a
clinical diagnosis of depression.28 Only 20 (7%)
of the 300 rural women screened for depressive
symptoms did not meet the inclusion criteria.
Demographic characteristics of the sample
are summarized in Table 1. The sample was
largely single (83%), African American women
(82%) living alone with their children. Forty-
three percent of the sample reported annual
household incomes less than $5,000, and 78%
less than $10,000. Just over half of the sample
lived in small towns and nearly half lived on
rural routes. The age of participants ranged
from 18 to 66 years, with a mean age of 39.75
years (standard deviation [SD]  10.37 years).
Forty-one percent of the participants had not
earned a high school degree. Only a small por-
tion of the sample (21%) was employed either
full or part time. Some of these women had a
clinical diagnosis of depression and were on
antidepressant medications and/or counsel-
ing. However, depression was not a focus of
this particular analysis. Patterns of risk for de-
pression among this sample and its influence
on medication adherence are described else-
where.29,30
Procedures
The staff of cooperating agencies served as
intermediaries for the investigators in recruit-
ment by distributing information about the
study to potential participants. Women who
were interested in participating in the study
and gave their consent were contacted by fe-
male research assistants hired from the local
area who received intensive training in re-
cruitment and interviewing techniques. An ini-
tial meeting was scheduled to explain the study
procedures and to complete the process of in-
formed consent and screening to determine
whether or not they met the study inclusion cri-
teria. Those who met the criteria were sched-
uled for an initial interview conducted at the
participant’s home or other mutually agreed-
upon site where privacy and confidentiality
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TABLE 1. SAMPLE DEMOGRAPHICS (n  224)
Variable Levels Frequency %
Race African American (0) 183 81.7
Other (1) 41 18.3
Age (years) 18–30 (0) 43 19.2
31–45 (1) 115 51.3
 45 (2) 65 29.0
Missing 1
Education Less than HS degree (0) 92 41.1
HS degree (1) 72 32.1
College/technical training (2) 60 26.8
Annual household income $5,000 (0) 97 43.3
 $5,000–$9,999 (1) 77 34.4
$10,000 and higher (2) 50 22.3
Employed full/part time No (0) 176 78.6
Yes (1) 48 21.4
Marital status Singlea (0) 186 83
Non-singleb (1) 38 17
Living situation Live alone (0) 40 18
Live with others (1) 184 82
Live in town? No (0) 114 51
Yes (1) 109 49
Missing 1
Numbers in parentheses following categorical variables designate coding level for multivariate levels.
aThis category includes those never married, separated, divorced or widowed.
bThis category includes those married or living with a partner.
could be maintained. Research assistants read
all interview items to the participants and
recorded their responses. Interviews lasted
from one to two hours, and participants were
paid $30.
Instruments
The properties of study instruments are sum-
marized in Table 2.
Social support. Social support was mea-
sured using two scales that together measure
the three major dimensions of social support
identified in the literature: the functional com-
ponents of social support (availability of dif-
ferent types of support), the source of support
(network), and the quality of available support
(e.g., satisfaction). The functional component of
social support was measured by the Medical
Outcomes Study Social Support Survey (MOS-
SSS).31 Developed for use with chronically ill
patients, the scale is designed to measure the
individual’s perception of the availability of
support along four dimensions: emotional/in-
formational, affectionate, tangible, and positive
social interaction. The 19 items describe the dif-
ferent types of support, rated on a 5-point re-
sponse format of how often a type of support
is available if needed, with responses ranging
from none of the time (1) to all of the time (5).
Higher scores reflect higher levels of perceived
availability.
The short form of the Social Support Ques-
tionnaire (SSQ6)32 was used to measure both
the source of support and satisfaction with so-
cial support. The SSQ6 contains six items de-
rived from the original 27-item SSQ.33 Social
support was measured in two parts. The num-
ber of available support persons was measured
by asking the respondent to list up to nine peo-
ple on whom they can rely for the set of cir-
cumstances described in each item. The degree
of satisfaction with available support was then
measured for each item using a 6-point re-
sponse format ranging from very satisfied (6)
to very dissatisfied (1). For the present analy-
sis we focused on availability and quality (sat-
isfaction) of social support.
Coping. Coping responses were measured
by the Family Coping Project Coping Scale
(FCPCS).34,35 The scale was developed using
516 descriptions of coping collected from 267
HIV-infected women from rural and urban ar-
eas enrolled in a longitudinal study of women’s
responses to HIV/AIDS. Using qualitative
analysis, major categories of coping were iden-
tified and items representing each category
were developed; a 54-item scale resulted. Ex-
ploratory factor analysis using data collected
with the instrument in subsequent interviews
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TABLE 2. PROPERTIES OF STUDY INSTRUMENTS
Statistics for sample
Measure Subscales # Items Range Mean SD 
Social support Availability of support
Sources of support 6 0–6 5.12 1.74 0.97
Satisfaction with support 6 5–36 29.04 10.01 0.97
Family Coping Project Coping Scale Total coping 54 49–142 100.16 17.40 0.87
Living positively 9 1–27 20.96 4.74 0.80
Managing the illness 8 6–24 19.18 4.14 0.78
Seeking support family 7 0–21 12.14 5.01 0.82
Isolation/withdrawal 7 0–21 11.64 4.43 0.69
Spiritual activities 5 1–15 11.74 2.90 0.76
Seeking information 2 0–6 4.47 1.56 0.65
Denial/avoidance 6 0–18 9.32 3.90 0.66
Seeking peer support 9 0–23 10.73 4.89 0.67
Reasons for missed medications — 14 0–42 9.31 10.42 0.95
Note: The second proxy variable for the medicine adherence was missed HIV-medication, which was dichotomized
into two categories of never missed medications (0) indicating complete adherence and missed medication at least
once in previous month (1) indicating nonadherence.
SD, standard deviation.
with the women generated five valid and reli-
able subscales: avoidance/denial, managing
the illness, spiritual activities, seeking social
support, and focusing on others. The construct
validity of the instrument for the current sam-
ple of rural women with HIV was assessed us-
ing principal components factor analysis. Eight
valid and reliable coping factors were identi-
fied for the study sample (Table 2). Each item
was rated on a 4-point response format of the
frequency each strategy had been used in the
past 3 months, with responses ranging from
never (1) to always (4). The items comprising
each factor were summed for a total subscale
score.
The coping responses represented by the fac-
tors are similar to those identified in other mea-
sures of coping. However, a coping response
unique to women with HIV disease was man-
aging the illness. The items making up this fac-
tor represent efforts to promote and maintain
health and include such behaviors as practic-
ing healthy habits like eating right, exercising,
and getting enough rest, avoiding drugs and
alcohol, and keeping health care appointments.
Medication adherence. Medication adherence
was measured by two proxy variables: self re-
ported missed HIV-medications and reasons
for missed medications in the past month. For
the purpose of this study, responses to items
about missed HIV-medications were used to
categorize study participants into two cate-
gories of complete adherence (never missed
medications) or nonadherence (missed med-
ications at least once in previous month). This
approach was used because previous research
has indicated that nearly 100% adherence to
HAART is necessary to obtain the best results.
The second proxy variable, the frequency of
self-reported reasons for missed medications in
the past month, was assessed by a modified
version of the Adult AIDS Clinical Trials Group
Adherence Baseline Questionnaire.36,37 Rea-
sons for missed medications was a continuous
score based on 14 commonly reported reasons
for missed medications rated on a 4-point scale
ranging from 0 (never) to 3 (often). When these
14 items were summed for a total score; higher
scores indicated a greater degree of endorse-
ment of reasons for missed medications. Factor
analysis of the reasons for missed medications
yielded only one factor suggesting that all the
responses measured the same construct. Inter-
nal consistency reliability of the scale for the
sample was high (  0.95).
ANALYSES
Frequencies and percentages were calculated
to determine the distribution of the sample on
sociodemographic variables. 2 test was per-
formed to determine which sociodemographic
variables were significantly associated with
medication adherence variables. Pearson’s cor-
relations and analysis of variance were used to
determine which social support, and coping
variables were related to adherence variables
and should be included in subsequent analy-
ses. The dependent variable was regressed on
the variables found significant in the prelimi-
nary analysis to identify the significant predic-
tors of adherence.
The mediating effect of coping was analyzed
in three steps using those social support, cop-
ing, and medication adherence variables that
were found to be significantly associated. First,
simple regression analysis was performed for
reasons for missed medications on social sup-
port variables. Next, simple regression analy-
sis was performed for each of the coping vari-
ables that were found to be significantly
associated with social support variables, using
social support as an independent variable. In
the third step, the focus was on the outcome of
self-reported reasons for missed medications in
the past month. Three sets of multiple regres-
sion analyses were performed for missed med-
ications on each of the social support and cop-
ing variables that were found significant in the
earlier steps.
For the other proxy variable, t tests were
used to identify the differences in the means of
predictor variables for the two adherence lev-
els: never missed medications and missed med-
ications at least once in the previous month.
Significant social support and coping variables
were then entered into logistic regression anal-
ysis to estimate the odds that they were signif-
icant predictors of the two levels of missed
medications: (1) participants with scores of 0
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indicating no missed medications in the past
month and (2) participants with scores greater
than 0 indicating some degree of missed med-
ications in the past month. The significance
level for all analyses was set at p  0.05.
In addition, Pearson’s correlations were per-
formed to explore the patterns of relationships
that might be present among the various rea-
sons for missed medications and the social sup-
port variables.
FINDINGS
Of the 280 women in the study sample, 224
were receiving combination antiretroviral ther-
apy at the time of interview and thus were in-
cluded in the analyses. Of these, 81 (36.16%) re-
ported never skipping medications, while 133
(59.38%) were nonadherent to their medication
regimen to various extents in the past month;
10 refused to provide relevant data. Approxi-
mately 25% of the participants reported miss-
ing doses of their medications within the past
2 weeks. Of all the sociodemographic, social
support and coping variables considered indi-
vidually, 8 were significantly correlated with
the measure of reasons for missed medications
(Table 3). Two variables, coping by denial/
avoidance (p  0.0002), and number of children
given birth to (p  0.005), were positively cor-
related with reasons for missed medications,
while availability of social support (p  0.01)
and coping by spiritual activities (p  0.005),
managing HIV disease (p  0.0001), positive
thinking (p  0.0001), focusing on others (p 
0.02), and focusing on the present (p  0.0003),
were negatively correlated with reasons for
missed medications. Next, in multiple regres-
sion analysis, the measure of reasons for
missed medications was regressed on the sig-
nificant covariates (Table 4). The regression
model was significant (F  11.55; p  0.0001)
and accounted for 30% of the variability in rea-
sons for missed medications. Three of the 8
variables entered in the regression model were
significant predictors. Coping by denial/avoid-
ance (p  0.0001), and number of children
given birth to (p  0.0003) were positive pre-
dictors of reasons for missed medications,
whereas coping by managing HIV disease (p 
0.0001) was a negative predictor. When non-
significant variables were eliminated from the
model using backward stepwise regression
analyses; there were only minor changes in the
adjusted R2 value.
Two out of the three coping variables exam-
ined, focusing on the present and spiritual ac-
tivities, were found to mediate the effect of so-
cial support on reasons for missed medication
(Table 5). In the first step of the analysis, the
score for reasons for missed medications was
regressed on available social support and the
model was significant (p  0.0161). In the next
step, each of the three coping variables (focus-
ing on others, focusing on present and spiritual
activities) was individually regressed on avail-
able social support, and each of the models was
significant (p  0.002, p  0.0032, and p 
0.0029, respectively). In the final step, three sep-
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TABLE 3. PEARSON’S CORRELATIONS BETWEEN PREDICTOR
VARIABLES AND REASONS FOR MISSED MEDICATIONS
Predictor variables Reasons for missed medications
Availability of social support 0.16a
Satisfaction with available support 0.08
Coping: denial/avoidance 0.25a
Coping: seeking social support 0.05
Coping: spiritual activities 0.19a
Coping: managing HIV disease 0.40a
Coping: focusing on others 0.16a
Coping: positive thinking 0.31a
Coping: focus on present 0.24a
Coping: information seeking 0.12
Number of children given birth to 0.19a
ap  0.05.
arate regression analyses were performed with
reasons for missed medication regressed on
available social support in combination with
each of the three coping variables. The results
indicated that coping by the use of spiritual ac-
tivities and focusing on the present each medi-
ated the effect of social support on the outcome
variable (p  0.02, and p  0.001, respectively).
Social support, which was a significant predic-
tor of adherence in the first step, became non-
significant in the third step when coping vari-
ables were added to the models, with the cop-
ing variables (use of spiritual activities and
focusing on the present) being the significant
predictors of adherence.
Scores on the second measure of medication
adherence, self-reported missed medications in
the past month, were used to group partici-
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TABLE 4. MULTIPLE REGRESSION ANALYSIS OF REASONS FOR MISSED MEDICATIONS ON PREDICTOR VARIABLES
Variable statistics Model statistics
Variable  Standard error p F p R2 Adjusted R2
Availability of social support 0.4375 0.3628 0.2291 11.55  0.0001 0.3036 0.2773
Coping: denial/avoidance 0.3869 0.0955  0.0001a
Coping: spiritual activities 0.0127 0.1908 0.9470
Coping: focusing on others 0.0445 0.3096 0.8860
Coping: managing HIV disease 0.8007 0.1734  0.0001a
Coping: positive thinking 0.5421 0.4350 0.2141
Coping: focus on present 0.9808 0.5989 0.1030
Number of children given birth to 1.1933 0.3257 0.0003a
ap  0.05.
TABLE 5. COPING AS MEDIATOR BETWEEN AVAILABLE SOCIAL SUPPORT AND REASONS FOR MISSED MEDICATIONS
Step 1: Simple Regression Analysis of Reasons for Missed Medications on Available Social Support
Variable statistics
Variable  Standard error p
Available Social Support 0.9840 0.4056 0.0161
Step 2: Simple Regression Analysis of Selected Coping Variables on Available Social Support
Variable statistics for
available social support
Dependent variable  Standard error p
Coping: Focusing on others 0.2967 0.0948 0.0020
Coping: Focus on Present 0.1423 0.0471 0.0029
Coping: Spiritual Activities 0.4322 0.1452 0.0032
Step 3: Multiple Regression Analysis of Reasons for Missed Medications on Predictor Variables
Variable statistics Model statistics
Independent variables  Standard error p F p R2 Adjusted R2
III Available Social Support 0.8263 0.4119 0.0461 4.74 0.0097 0.0415 0.0327
III Coping: Focusing on others 0.5359 0.2855 0.0618
III Available Social Support 0.7217 0.4051 0.0765 8.39 0.0003 0.0712 0.0627
III Coping: Focus on Present 1.8459 0.5659 0.0013a
III Available Social Support 0.7904 0.4094 0.0548 5.89 0.0032 0.0510 0.0423
III Coping: Spiritual Activities 0.4449 0.1854 0.0172a
aStatistically significant results for medication effect (for all analyses p  0.05).
pants into two adherence categories; those par-
ticipants who reported no missed medications
(adherent) coded as “0” and those participants
who missed one or more doses of medications
during the past month (non-adherent) coded as
“1.” t tests were conducted to identify the sig-
nificant differences in means of sociodemo-
graphic, social support, and coping variables
for the two groups (Table 6). Of the 12 variables
assessed, significant differences in means were
found for number of children (p  0.05), satis-
faction with available support (p  0.02), cop-
ing by managing illness (p  0.0003), and cop-
ing by positive thinking (p  0.049). Coping by
information seeking approached significance
(p  0.07). Significant variables were entered
into logistic regression analysis to determine
the odds they were significant predictors of ad-
herence/nonadherence categories (Table 7).
Satisfaction with available social support (p 
0.04), and coping by managing HIV disease
(p  0.002) were found to be the best positive
predictors of drug adherence, whereas number
of children (p  0.02) was found to be a nega-
tive predictor of medication adherence.
An additional analysis was conducted to ex-
amine the pattern of relationships between so-
cial support and the reasons for missed med-
ication items. Seven of the 14 reasons for
missed medications were significantly nega-
tively correlated with availability of social sup-
port (Table 8): (1) had too many pills; (2)
wanted to avoid side effects; (3) did not want
others to notice; (4) fell asleep; (5) felt sick; (6)
felt depressed; and (7) problem taking pills at
specified times.
DISCUSSION
Findings of the study demonstrated that of
the 224 women in the sample receiving combi-
nation antiretroviral therapy, 133 (59.38%)
were nonadherent to their drug regimens at
least once during the past month. This finding
is consistent with the reported rates of nonad-
herence to antiretroviral therapy in previous
research.21 However; it is relatively high com-
pared to the rates reported by recent stud-
ies.22–24 The finding supports that medication
adherence is an important issue for rural
women with HIV disease.
In this study we examined the role of so-
cial support and coping strategies in adher-
ence to the complex multidrug regimens for
HIV infection. Previous research has clearly
demonstrated the importance of maintaining
a nearly perfect adherence to anti-retroviral
drug regimens in order to decrease morbid-
ity and mortality, to improve the quality of
life of HIV-infected individuals, and to pre-
vent development of drug resistant strains of
the virus.2,4 Social support and coping are par-
ticularly important because they can be modi-
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TABLE 6. t-TEST STATISTICS OF SELECTED ANTECEDENT VARIABLES BY
MISSED MEDICATION GROUP (ADHERENT VS. NONADHERENT)
Never missed medication Missed medication
Variable n Mean SD n Mean SD p Value
Availability of social support 81 5.284 1.60 133 5.008 1.79 0.24
Satisfaction with available supporta 80 30.963 8.94 132 27.758 10.54 0.02
Coping: avoidance 81 18.235 6.11 133 19.383 6.59 0.20
Coping: seeking social support 81 21.704 7.72 133 20.835 7.38 0.42
Coping: spiritual activities 81 16.198 3.99 133 15.406 3.66 0.15
Coping: managing illnessa 81 22.543 3.36 133 20.579 4.47 0.0003
Coping: focusing on others 81 9.432 2.55 133 9.226 2.46 0.56
Coping: positive thinkinga 80 7.325 1.74 133 6.805 1.94 0.04
Coping: focus on present 81 4.914 1.24 133 4.940 1.21 0.88
Coping: information seeking 81 11.506 2.80 133 10.714 3.55 0.07
Number of childrena 81 2.173 1.53 133 2.65 2.04 0.05
ap  0.05.
Note: the observations (n) do not add to 224 due to missing data.
SD, standard deviation.
fied through a variety of intervention ap-
proaches, including cognitive, behavioral, and
social approaches.
The finding that coping by denial/avoidance
was a predictor of non-adherence to medica-
tions was not unexpected. Denial has long been
associated with poor outcomes in chronic ill-
nesses. Similarly, the finding that coping by
managing HIV disease was a negative predic-
tor of nonadherence was expected as this cop-
ing strategy represents an active approach to
taking control of the disease through health
promoting behaviors. This was consistent with
the findings of other researchers who reported
that individuals who engaged in more active
coping in response to HIV-related life stressors
were more likely to adhere to their medication
regimens.27 It was interesting to note that the
number of children given birth to had an in-
fluence on medication adherence, such that the
number of reported missed medications in-
creased as the number of children increased. A
well-established fact in women’s health is that
women very often put the needs of their chil-
dren above their own,38 and this is a possible
explanation for the association between num-
ber of children and adherence.
We also found that coping by the use of spir-
itual activities and focusing on the present both
mediated the effect of social support on med-
ication adherence. There are several possible
explanations for this finding. First, the sample
was recruited from the southern United States,
an area known to be dominated by conserva-
tive values and norms that include religion.
Furthermore, the large majority of the sample
was African American, and religion is a core
component of the southern African American
culture. Additionally, the church is a valued
source of support in the southern African
American culture. Ethnographic studies have
found that African American women’s spiri-
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TABLE 7. SUMMARY OF LOGISTIC REGRESSION ANALYSIS PREDICTING
MISSED MEDICATION GROUP (ADHERENT VS. NONADHERENT)
Variable  Standard error Odds ratio 95% Confidence interval
Satisfaction with available supporta 0.0326 0.0163 1.033 1.001–1.067
Coping: Managing HIV diseaseb 0.1493 0.0490 1.161 1.055–1.278
Coping: Positive thinking 0.0039 0.0993 0.996 0.820–1.210
Coping: Information seeking 0.0016 0.0531 1.002 0.903–1.112
Number of Childrena 0.1933 0.0844 0.824 0.699–0.973
ap  0.05.
ap  0.01.
Note: 13 observations were deleted due to missing values for the response or explanatory variables.
TABLE 8. PEARSON’S CORRELATIONS BETWEEN EACH OF THE REASONS
FOR MISSED MEDICATIONS AND AVAILABLE SUPPORT
Reasons for missed medications Correlation coefficient p value
Away from home 0.01 0.83
Busy with other things 0.09 0.16
Simply forgot 0.10 0.11
Had too many pills 0.17 0.01a
Wanted to avoid side effects 0.13 0.04a
Did not want others to notice 0.15 0.03a
Had a change in daily routine 0.11 0.10
Felt drug was toxic 0.08 0.22
Fell asleep 0.14 0.03a
Felt sick/ill 0.20 0.00a
Felt depressed 0.19 0.00a
Problem taking pills at specified times 0.16 0.02a
Ran out of pills 0.08 0.26
Felt good 0.07 0.31
aSignificant correlations.
tual beliefs are often linked closely to beliefs
about health, disease, and behavior.39 One
study in particular examined the association of
religion, religious beliefs and practices with
treatment adherence among individuals with
HIV disease in one of the southern states.40 The
results of this study indicated that certain reli-
gious practices and beliefs were among the
multiple factors influencing adherence. The
role of focusing on the present in this equation
is less clear. Focusing on the present is an im-
portant coping strategy for effective stress
management. By focusing on the present, one
is less likely to focus on the future threats posed
by the illness, and hence, less distress is gen-
erated.12 Because individuals with chronic ill-
ness frequently learn how to cope with the ill-
ness through their interaction with others with
the disease, the support received from others
with HIV disease could be a factor accounting
for the use of this coping strategy by the
women in this study.
Coping by managing HIV disease was found
to be an important predictor of medication ad-
herence. The finding suggests that a belief in
one’s ability to control the disease may be the
key to adherence. This is consistent with the
theory of psychological stress and coping,
where emphasis is placed on the importance of
belief in one’s ability to affect outcomes by ef-
fectively coping with difficult life situations
such as chronic illness.12 Satisfaction with so-
cial support was also found to be a significant
predictor of medication adherence, a finding
that is consistent with current thought on the
importance of the match between the type of
support that is available and what is desired or
needed to effectively cope with a specific situ-
ation.12 Satisfaction with available support is a
good indicator of the quality of this match.
However, the findings do not provide insight
into the specific types of support that may pro-
mote medication adherence within the context
of HIV disease. Further research is needed to
identify the types of support that are not only
the most satisfying within the context of HIV
disease, but which also support positive out-
comes such as adherence to medications. Such
findings are central to the development of pre-
dictably effective social support interventions
for medication adherence. Despite such limita-
tions, the findings support the need to assess
the individual’s perception of the support they
want and/or need in order to achieve adher-
ence to their medication regimen.
The study is limited in several ways. Med-
ication adherence was assessed by self-report
and true adherence levels are often overesti-
mated when self-reported.41 The reduction of
data for missed medications into adherent and
nonadherent categories reduces variability in
the dependent variable and this may have been
a factor in findings of nonsignificance of some
independent variables. The scope of the analy-
sis was limited to an examination of social sup-
port and coping as predictors of medication ad-
herence, and there may be other important
predictors not represented in this analysis. The
relationship among medication adherence and
two such predictors, sleep disturbance and de-
pression, are reported elsewhere.30 Future re-
search is warranted to identify such factors and
understand their relation to medication adher-
ence. Another limitation is the exclusion of
HIV-positive women with CESD scores of less
than 16, and it is possible that the dynamics of
medication adherence may differ for women
who are not depressed. Additionally, the sam-
ple was limited to rural women from one geo-
graphic region of the United States and the re-
sults cannot be generalized to women from
urban areas or other geographic regions.
It is well established that adherence to HIV
medication is a key factor in managing the pro-
gression of the disease. The findings of the
study have implications in designing, imple-
menting, and testing interventions based on so-
cial support and coping theories. Social support
and coping are particularly important because
they can be modified through a variety of in-
tervention approaches, including cognitive, be-
havioral, and social approaches.
CONCLUSION
Findings indicate that social support and
coping strategies influence adherence to anti-
retroviral drug regimens among rural women
with HIV disease. It is not mere availability of
social support, but the satisfaction of the avail-
able support which is important for better ad-
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herence. Coping by spiritual activities and fo-
cusing on the present mediated the effect of so-
cial support on medication adherence. Satis-
faction with available support and coping by
managing HIV disease were the best positive
predictors of medication adherence, whereas
the number of children was a negative predic-
tor of medication adherence. Further research
is warranted to identify and better understand
the complex factors influencing drug adher-
ence among different populations and in dif-
ferent geographic regions.
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